Precigen (PGEN) Interest Coverage Ratio: History & Chart

Precigen, Inc.(PGEN)

Biotechnology · Germantown, MD

$7.61-0.13 (-1.63%)

Delayed quote: Oct 6, 2026, 1:05 PM EDT

About Precigen, Inc.

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.

Germantown, MD

160 employees

www.precigen.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Helen Sabzevari

View full financials

PGEN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-27.57x

INTEREST COVERAGE RATIO AVG TTM

-9.98x

INTEREST COVERAGE RATIO AVG 3Y

-9120.68x

INTEREST COVERAGE RATIO AVG 5Y

-1657.60x

INTEREST COVERAGE RATIO AVG 10Y

-84.97x

INTEREST COVERAGE RATIO AVG 15Y

-161.16x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-176.18%

CURRENT VS 3Y AVG

+99.70%

CURRENT VS 5Y AVG

+98.34%

CURRENT VS 10Y AVG

+67.55%

CURRENT VS 15Y AVG

+82.89%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-5.87x

median of 489 covered companies

CURRENT VS SECTOR MEDIAN

-369.68%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Precigen, Inc. (PGEN)	$2.71B	-27.57x	-9.98x	-9120.68x	-1657.60x
Aveanna Healthcare Holdings Inc. (AVAH)vs ›	$2.67B	1.89x	1.89x	0.94x	0.94x
Acadia Healthcare Company, Inc. (ACHC)vs ›	$2.67B	2.79x	3.64x	5.04x	5.11x
MBX Biosciences, Inc. Common Stock (MBX)vs ›	$2.67B	N/A	N/A	N/A	N/A
Neogen Corporation (NEOG)vs ›	$2.66B	-0.37x	0.59x	204.00x	353.37x
AtriCure, Inc. (ATRC)vs ›	$2.79B	-0.59x	11.23x	11.23x	11.23x
TransMedics Group, Inc. (TMDX)vs ›	$2.81B	7.88x	5.24x	5.24x	5.24x
Dyne Therapeutics, Inc. (DYN)vs ›	$2.83B	-75.61x	0.12x	0.12x	0.12x
Privia Health Group, Inc. (PRVA)vs ›	$2.58B	N/A	7.78x	5.30x	5.30x
Beam Therapeutics Inc. (BEAM)vs ›	$2.58B	-8.77x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Precigen, Inc. (PGEN)

$2.71B

-27.57x

-9.98x

-9120.68x

-1657.60x

Aveanna Healthcare Holdings Inc. (AVAH)vs ›

$2.67B

1.89x

0.94x

Acadia Healthcare Company, Inc. (ACHC)vs ›

$2.67B

2.79x

3.64x

5.04x

5.11x

MBX Biosciences, Inc. Common Stock (MBX)vs ›

$2.67B

N/A

Neogen Corporation (NEOG)vs ›

$2.66B

-0.37x

0.59x

204.00x

353.37x

AtriCure, Inc. (ATRC)vs ›

$2.79B

-0.59x

11.23x

TransMedics Group, Inc. (TMDX)vs ›

$2.81B

7.88x

5.24x

Dyne Therapeutics, Inc. (DYN)vs ›

$2.83B

-75.61x

0.12x

Privia Health Group, Inc. (PRVA)vs ›

$2.58B

N/A

7.78x

5.30x

Beam Therapeutics Inc. (BEAM)vs ›

$2.58B

-8.77x

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Precigen, Inc. (PGEN)?

The interest coverage ratio for PGEN stock is -27.57x.

Is Precigen, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -27.57x is 98% above its 5-year average of -1657.60x, near the high end of its 5-year range (-30420.50x–7.67x).

What is the TTM average interest coverage ratio for Precigen, Inc. (PGEN)?

The TTM average interest coverage ratio for PGEN stock is -9.98x.

What is the 3Y average interest coverage ratio for Precigen, Inc. (PGEN)?

The 3Y average interest coverage ratio for PGEN stock is -9120.68x.

What is the 5Y average interest coverage ratio for Precigen, Inc. (PGEN)?

The 5Y average interest coverage ratio for PGEN stock is -1657.60x.

What is the 10Y average interest coverage ratio for Precigen, Inc. (PGEN)?

The 10Y average interest coverage ratio for PGEN stock is -84.97x.

What is the 15Y average interest coverage ratio for Precigen, Inc. (PGEN)?

The 15Y average interest coverage ratio for PGEN stock is -161.16x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	7.67x
2026-03-31	-2.06x
2025-12-31	-7.31x
2025-09-30	-38.23x
2025-03-31	-22596.00x
2024-09-30	-10631.00x
2024-06-30	-30420.50x
2024-03-31	-12206.50x
2023-12-31	-3341.29x
2023-09-30	-20937.00x
2023-06-30	-155.29x
2023-03-31	-72.46x
2022-12-31	-34.22x
2022-09-30	-3.74x
2022-06-30	-11.71x
2022-03-31	-10.87x
2021-12-31	-4.48x
2021-09-30	-4.52x
2021-06-30	-5.66x
2021-03-31	-7.15x
2020-12-31	0.78x
2020-09-30	-4.95x
2020-06-30	-2.58x
2020-03-31	-3.61x
2019-12-31	-13.10x
2019-09-30	-10.87x
2019-06-30	-8.58x
2019-03-31	-13.62x
2018-12-31	-78.53x
2018-09-30	-16.62x
2018-06-30	-350.25x
2018-03-31	-489.64x
2017-12-31	-234.44x
2017-09-30	-324.25x
2017-06-30	-194.86x
2017-03-31	-175.31x
2016-12-31	-319.51x
2016-09-30	-126.96x
2016-06-30	-86.97x
2016-03-31	-152.95x
2015-12-31	-148.25x
2015-09-30	-25.54x
2015-06-30	-48.55x
2015-03-31	-254.00x
2014-12-31	-53.11x
2014-09-30	-65.42x
2014-06-30	-452.05x
2014-03-31	-458.26x
2013-12-31	-161.15x
2013-09-30	-2006.17x
2013-06-30	-1295.82x
2013-03-31	-1000.43x
2012-12-31	-820.20x
2012-09-30	-969.71x
2012-06-30	-1180.44x
2012-03-31	-3588.71x

DATE

INTEREST COVERAGE RATIO

2026-06-30

7.67x

2026-03-31

-2.06x

2025-12-31

-7.31x

2025-09-30

-38.23x

2025-03-31

-22596.00x

2024-09-30

-10631.00x

2024-06-30

-30420.50x

2024-03-31

-12206.50x

2023-12-31

-3341.29x

2023-09-30

-20937.00x

2023-06-30

-155.29x

2023-03-31

-72.46x

2022-12-31

-34.22x

2022-09-30

-3.74x

2022-06-30

-11.71x

2022-03-31

-10.87x

2021-12-31

-4.48x

2021-09-30

-4.52x

2021-06-30

-5.66x

2021-03-31

-7.15x

2020-12-31

0.78x

2020-09-30

-4.95x

2020-06-30

-2.58x

2020-03-31

-3.61x

2019-12-31

-13.10x

2019-09-30

-10.87x

2019-06-30

-8.58x

2019-03-31

-13.62x

2018-12-31

-78.53x

2018-09-30

-16.62x

2018-06-30

-350.25x

2018-03-31

-489.64x

2017-12-31

-234.44x

2017-09-30

-324.25x

2017-06-30

-194.86x

2017-03-31

-175.31x

2016-12-31

-319.51x

2016-09-30

-126.96x

2016-06-30

-86.97x

2016-03-31

-152.95x

2015-12-31

-148.25x

2015-09-30

-25.54x

2015-06-30

-48.55x

2015-03-31

-254.00x

2014-12-31

-53.11x

2014-09-30

-65.42x

2014-06-30

-452.05x

2014-03-31

-458.26x

2013-12-31

-161.15x

2013-09-30

-2006.17x

2013-06-30

-1295.82x

2013-03-31

-1000.43x

2012-12-31

-820.20x

2012-09-30

-969.71x

2012-06-30

-1180.44x

2012-03-31

-3588.71x

Interest Coverage Ratio: -27.57x

PGEN Interest Coverage Ratio

PGEN Average Interest Coverage Ratio Chart

PGEN Current vs Average Interest Coverage Ratio Chart

PGEN Interest Coverage Ratio Metrics

PGEN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

PGEN Interest Coverage Ratio History

Related Metrics